Wednesday, February 10, 2010, 11:46AM AEST - The Australian Stockmarket closes in 4 hours and 19 minutes.
To create a watchlist or portfolio of shares, Register

Acorda Therapeutics, Inc. (ACOR)

8:00AM AEST: 29.99 USD  Up 0.07 (0.23%)  
 MORE ON ACOR 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Acorda Therapeutics, Inc. (NGM:ACOR) Delayed quote dataEdit
Last Trade:29.99 USD
Trade Time: 8:00AM AEST
Change:Up 0.07 (0.23%)
Prev Close:29.92
Open:30.18
Bid:27.75 x 600
Ask:30.74 x 300
1y Target Est:30.00
Day's Range:29.94 - 30.43
52wk Range:15.52 - 31.78
Volume:954,133
Avg Vol (3m):782,958
Market Cap:1.14B
P/E (ttm):N/A
EPS (ttm):-2.17
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add ACOR to Portfolio   Download Data

 HEADLINES 
'Mad Money Lightning Round': Rambus Heading Higher
at TheStreet.com (Wed 11:35AM)
Cramer's 'Mad Money' Recap: The Catalysts Behind the Rally (Final)
at TheStreet.com (Wed 11:26AM)
[video] Acorda Therapeutics CEO on Drug Pricing
at CNBC (Tue 5:15AM)
4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC (Tue 2:34AM)
Is Biotech Back?
CNBC (Tue 1:31AM)
[video] Is Biotech Back?
at CNBC (Tue 12:08AM)
Wild Weekly Wrap-Up: Everyone Just Relax
at Seeking Alpha (Mon, Feb 8)
Acorda Therapeutics downgraded by Robert W. Baird
Briefing.com (Thu, Feb 4)
Acorda's Lucky Number 13
at CNBC (Thu, Feb 4)
Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire (Wed, Feb 3)
ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Feb 3)
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Business Wire (Wed, Feb 3)
ACORDA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Jan 29)
More Headlines for ACOR...

 ANALYST 
EPS Est (next year) (Dec-09) :-2.22
EPS Est (in 2 years) (Dec-10) :-1.68
Avg Rec (current)*:1.9
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices